RxDoctor Payments DataLook up a doctor →

Le-Chu Su, MD

Gastroenterology · New York, NYNPI 1457428781

Payments from drug & device makers

$948,636in general payments, 2019–2025

Across 389 payments — averaging $2438.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$442K
  • Eli Lilly$352K
  • Takeda Pharmaceuticals U.S.A., Inc.$151K
  • Johnson & Johnson$2K
  • Pfizer$633
  • Lilly USA, LLC$281
  • plus $797 from 9 others
$64in research payments, 2019–2025

Across 1 payment — averaging $64.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$64

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$948,636 in reported general payments places this provider in the 95th percentile of 1,682 gastroenterology providers in New York.

See all gastroenterology providers in New York

Medicare billing

Part B allowed, 2024
$43,603
Medicare patients
96
Services billed
315

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →